NouBio Inc is a cell-based human longevity company with access to next generation deep technologies to transform the $7 trillion longevity industry.

 

​

The founding team is focused on the bio-intelligent manufacturing of animal serum replacements & artificial intelligence driven biocomputer deep technologies to reduce the costs of cell-based biomanufacturing by 95% & scale the production of novel cell-based human longevity applications.

​

​​

NouBio's deep technologies scale production in multiple industries that impact the progression of cell-based human longevity including cell-therapies, cell-vaccines, human tissue creation, cell-based blood, drug discovery, regenerative medicine, cell-based foods/materials, defense, & synthetic biology.

​​

​

First beta product:

​

NouSerum: A full Fetal Bovine Serum (FBS) replacement that reduces production costs by 95% with similar performance to FBS. 

​

NouSerum: 

​

-300 serum proteins found in FBS
-Is in the GRAS category of FDA
-Free from GMOs 
-Powder for scalability 
-Antimicrobial to reduce contamination 
-Can be stored at room temperature 
-GMP compliant 

​

Future products:

​

-Cost-effective, bio-degradable microcarriers with no need to remove cells in bioreactors

​

-An artificial intelligence driven robotic cellular biocomputer to replace the need for bioreactors and scale cell-based applications in the longevity industry

 

Email info@noubio.co